Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Chaker

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Laryngo- Rhino- Otologie|February 1, 2021
L Klimek, A M Chaker, M Cuevas
Laryngo- Rhino- Otologie|March 8, 2021
L Klimek, A M Chaker, M Cuevas
HNO|September 14, 2017
[Costs of allergic diseases and saving potential by allergen-specific immunotherapy : A personal assessment]L Klimek, A M Chaker, R Mösges
Laryngo- Rhino- Otologie|January 22, 2021
L Klimek, A M Chaker, M Cuevas
Laryngo- Rhino- Otologie|May 27, 2021
L Klimek, A M Chaker, M Cuevas, et al.
Clinical and Translational Allergy|February 4, 2016
An accelerated dose escalation with a grass pollen allergoid is safe and well-tolerated: a randomized open label phase II trialA M Chaker, B Al-Kadah, U Luther, et al.
Allergy|December 27, 2015
Current and future biomarkers in allergic asthmaU M Zissler, J Esser-von Bieren, C A Jakwerth, et al.
Rhinology|December 11, 2024
Nasal secretions trace epithelial type 2 response to allergen-specific immunotherapyC A Jakwerth, U M Zissler, M Oelsner, et al.
Mucosal Immunology|November 19, 2015
Interleukin-4 and interferon-γ orchestrate an epithelial polarization in the airwaysU M Zissler, A M Chaker, R Effner, et al.
Laryngo- Rhino- Otologie|September 30, 2021
L Klimek, U Förster-Ruhrmann, A G Beule, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Laryngo- Rhino- Otologie|February 1, 2021
L Klimek, A M Chaker, M Cuevas
Laryngo- Rhino- Otologie|March 8, 2021
L Klimek, A M Chaker, M Cuevas
HNO|September 14, 2017
[Costs of allergic diseases and saving potential by allergen-specific immunotherapy : A personal assessment]L Klimek, A M Chaker, R Mösges
Laryngo- Rhino- Otologie|January 22, 2021
L Klimek, A M Chaker, M Cuevas
Laryngo- Rhino- Otologie|May 27, 2021
L Klimek, A M Chaker, M Cuevas, et al.
Clinical and Translational Allergy|February 4, 2016
An accelerated dose escalation with a grass pollen allergoid is safe and well-tolerated: a randomized open label phase II trialA M Chaker, B Al-Kadah, U Luther, et al.
Allergy|December 27, 2015
Current and future biomarkers in allergic asthmaU M Zissler, J Esser-von Bieren, C A Jakwerth, et al.
Rhinology|December 11, 2024
Nasal secretions trace epithelial type 2 response to allergen-specific immunotherapyC A Jakwerth, U M Zissler, M Oelsner, et al.
Mucosal Immunology|November 19, 2015
Interleukin-4 and interferon-γ orchestrate an epithelial polarization in the airwaysU M Zissler, A M Chaker, R Effner, et al.
Laryngo- Rhino- Otologie|September 30, 2021
L Klimek, U Förster-Ruhrmann, A G Beule, et al.
Pageof 2